ReWalk Robotics (NSDQ:RWLK) saw shares plummet as it reported 2nd quarter earnings that widely missed analysts marks and larger losses compared to the same quarter last year. ReWalk reported losses of $5.8 million, or 48¢ per share, on sales of $610,000 for the 3 months ended June 30. That amounts to a 23.8% bottom-line loss on […]
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
September 12, 2014 by Brad Perriello
Two medical device makers are preparing initial public offerings for the coming weeks, breaking up a spree of biotech IPOs that have dominated the market.
ReWalk Robotics, formerly Argo Medical Technologies, is preparing an initial public offering worth up to $57.5 million, according to regulatory filings.
FDA regulators announced this evening that they approved for the U.S. market the 1st robotic exo-suit for helping patients with lower-body paralysis walk upright.
Called ReWalk , the motorized system is comprised of metal leg braces that strap around the legs and back, supplying movement to joints in the hips, knees and ankles. The system includes a watch-based remote that controls the suit’s movements and patients rely on crutches to provide stability.